Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Sievers

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|May 1, 1997
Expression of sialosyl-T and disialosyl-T antigens in erythroid cellsK Muroi, Y Amemiya, E L Sievers, et al.
Nucleic Acids Research|March 25, 1985
Sequence requirements for self-splicing of the Tetrahymena thermophila pre-ribosomal RNAJ V Price, G L Kieft, J R Kent, et al.
Blood|September 9, 2000
Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cellL J Cooper, K M Shannon, M R Loken, et al.
British Journal of Haematology|February 1, 1994
GATA-1 is expressed in acute erythroblastic leukaemiaH Ekert, E L Sievers, A Tan, et al.
Current Pharmaceutical Design|December 5, 2000
Understanding and exploiting nature's chemical arsenal: the past, present and future of calicheamicin researchJ S Thorson, E L Sievers, J Ahlert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer GroupE L Sievers, B J Lange, P M Sondel, et al.
Leukemia|December 1, 1995
Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer GroupE L Sievers, F O Smith, W G Woods, et al.
The Cancer Journal From Scientific American|February 24, 2000
Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemiaE L Sievers, B J Lange, P M Sondel, et al.
Blood|December 1, 1996
Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disordersD K Miles, M H Freedman, K Stephens, et al.
Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|May 1, 1997
Expression of sialosyl-T and disialosyl-T antigens in erythroid cellsK Muroi, Y Amemiya, E L Sievers, et al.
Nucleic Acids Research|March 25, 1985
Sequence requirements for self-splicing of the Tetrahymena thermophila pre-ribosomal RNAJ V Price, G L Kieft, J R Kent, et al.
Blood|September 9, 2000
Evidence that juvenile myelomonocytic leukemia can arise from a pluripotential stem cellL J Cooper, K M Shannon, M R Loken, et al.
British Journal of Haematology|February 1, 1994
GATA-1 is expressed in acute erythroblastic leukaemiaH Ekert, E L Sievers, A Tan, et al.
Current Pharmaceutical Design|December 5, 2000
Understanding and exploiting nature's chemical arsenal: the past, present and future of calicheamicin researchJ S Thorson, E L Sievers, J Ahlert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Feasibility, toxicity, and biologic response of interleukin-2 after consolidation chemotherapy for acute myelogenous leukemia: a report from the Children's Cancer GroupE L Sievers, B J Lange, P M Sondel, et al.
Leukemia|December 1, 1995
Cell surface expression of the multidrug resistance P-glycoprotein (P-170) as detected by monoclonal antibody MRK-16 in pediatric acute myeloid leukemia fails to define a poor prognostic group: a report from the Childrens Cancer GroupE L Sievers, F O Smith, W G Woods, et al.
The Cancer Journal From Scientific American|February 24, 2000
Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemiaE L Sievers, B J Lange, P M Sondel, et al.
Blood|December 1, 1996
Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disordersD K Miles, M H Freedman, K Stephens, et al.
Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.
Pageof 3